Pluristem Therapeutics Inc (PSTI)

[Scott999]

Yes Mesoblast. Rah rah rah. Great for the space. Celularity is just a joke. But let's cheer Mesoblast. Lets look into them a little.

Founded in 2004. We were founded in 2001.

35 trials on Clinicaltrials. We have 6.

9 phase 3 trials. 2 completed, 3 recruiting, 4 awaiting results. We have 1 that just started.

How can this be? We started 3 years before them. We have the best product though right? After taking a look at Meso, I'm surprised we have the market cap we have. It ALL comes down to management, board, experience, CONNECTIONS, industry know how, the direction chosen, etc. All decided by management. What else can it be??? To deny this fact is a joke. I guess it is the controller right. Is that what you are going to believe??? I am open to other thoughts. Like usual, I will only expect one to twist it somehow, and another to congratulate.

Please go take a look at their management team. See the difference for yourselves. Just look at the overview of their management team. Then look at the big Pharma names most came from.

Mesoblast has a highly experienced management team made up of individuals who have held senior positions in international pharmaceutical and biotechnology companies. This team is responsible for the strategic direction, operations and success of our company.

Here's the link. Wipe the spit off your chin after.

http://mesoblast.com/company/management-team

And some snippets from the board. Again get some Kleenex handy for the chin.

Brian Jamieson, FCA

Chairman since 2007 after retiring as Chief Executive of Minter Ellison Melbourne. Previously he was CEO at KPMG Australia,

William M. Burns, BA

Mr Burns was Chief Executive Officer of Roche Pharmaceuticals from 2001 to 200@

Donal O’Dwyer, BE, MBA

he worked with Baxter Healthcare, rising from plant manager in Ireland to president of the Cardiovascular Group, Europe, now Edwards Lifesciences.

Ben-Zion Weiner, BSc, MSc, PhD

Dr Weiner has served on our Board of Directors since 2012. In a 37-year career at Teva Pharmaceutical Industries Ltd, he held various senior research and development positions, including Senior Vice President of Global Research and Development.